A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients

Infection Control and Hospital Epidemiology

Volumn 38, Issue 6, 2017, Pages 690-696

  Gaur, Aditya H ^a   Bundy, David G ^b   Werner, Eric J ^c   Hord, Jeffrey D ^d   Miller, Marlene R ^e   Tang, Li ^a   Lawlor, John P ^f   Billett, Amy L ^g  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Children's Specialty Group   (United States)

^d AKRON CHILDREN'S HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOMYCETALES INFECTION; ACTINOMYCOSIS; ARTICLE; BACILLACEAE INFECTION; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLOSTRIDIUM INFECTION; CORYNEBACTERIUM INFECTION; GASTROINTESTINAL INFECTION; GRAM POSITIVE INFECTION; HEMATOLOGIC MALIGNANCY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MICROCOCCUS; NEUTROPENIA; PEPTOSTREPTOCOCCUS; PROPIONIBACTERIUM ACNES; PROSPECTIVE STUDY; SECONDARY INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS VIRIDANS INFECTION; UNITED STATES; CARE BUNDLE; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; COMPLICATION; CROSS INFECTION; HEALTH SURVEY; HEMATOLOGIC DISEASE; HEMATOLOGY; HOSPITAL; HOSPITAL SUBDIVISIONS AND COMPONENTS; MULTICENTER STUDY; NOMENCLATURE; PHILOSOPHY; PROCEDURES; SEPSIS; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT;

BLOOD CULTURE; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; HEMATOLOGIC NEOPLASMS; HEMATOLOGY; HOLISTIC HEALTH; HOSPITAL UNITS; HOSPITALS, PEDIATRIC; HUMANS; NEUTROPENIA; PATIENT CARE BUNDLES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; SEPSIS; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 85020524052     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.57     Document Type: Article

References (26)

1. Ammann RA, Laws HJ, Schrey D, et al. Bloodstream infection in paediatric cancer centres-leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr 2015;174:675-686.
2. Marsteller JA, Hsu YJ, Weeks K. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative. Am J Infect Control 2014;42:S209-S215.
3. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for "preventable complications.". JAMA 2008;299:2197-2199.
4. Srinivasan A, Craig M, Cardo D. The power of policy change, federal collaboration, and state coordination in healthcareassociated infection prevention. Clin Infect Dis 2012;55: 426-431.
5. National Healthcare Safety Network. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc-clabscurrent.pdf. Published 2017. Accessed February 17, 2017.
6. Bundy DG, Gaur AH, Billett AL, He B, Colantuoni EA, Miller MR. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics 2014;134: e1678-e1685.
7. Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 2011;128:e1077-e1083.
8. Neu AM, Miller MR, Stuart J, et al. Design of the standardizing care to improve outcomes in pediatric end-stage renal disease collaborative. Pediatr Nephrol 2014;29:1477-1484.
9. Wong Quiles CI, Gottsch S, Thakrar U, Fraile B, Billett AL. Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients. Pediatr Blood Cancer 2017;64:324-329.
10. Simon A, Furtwangler R, Graf N, et al. Surveillance of bloodstream infections in pediatric cancer centers-What have we learned and how do we move on? GMS Hyg Infect Control 2016;11:Doc11. doi: 10.3205/dgkh000271.
11. Fraser TG, Gordon SM. CLABSI rates in immunocompromised patients: a valuable patient centered outcome? Clin Infect Dis 2011;52:1446-1450.
12. Preventing central line-associated bloodstream infections: a global challenge, a global perspective. The Joint Commission website. https://www.jointcommission.org/assets/1/18/CLABSI-Monograph.pdf. Published 2012. Accessed February 17, 2017.
13. Gaur AH, Miller MR, Gao C, et al. Evaluating application of the National Healthcare Safety Network central line-associated bloodstream infection surveillance definition: a survey of pediatric intensive care and hematology/oncology units. Infect Control Hosp Epidemiol 2013;34:663-670.
14. Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304:2035-2041.
15. Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010;31:1286-1289.
16. See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 2013;34:769-776.
17. Dandoy CE, Haslam D, Lane A, et al. Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratoryconfirmed bloodstream infections after stem cell transplantation. Biol Blood Marrow Transplant 2016;10.
18. Epstein L, See I, Edwards JR, Magill SS, Thompson ND. Mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBI): descriptive analysis of data reported to National Healthcare Safety Network (NHSN), 2013. Infect Control Hosp Epidemiol 2016;37:2-7.
19. Metzger KE, Rucker Y, Callaghan M, et al. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients. Infect Control Hosp Epidemiol 2015;36:119-124.
20. Shelburne SA III, Chaftari AM, Jamal M, et al. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer. Am J Infect Control 2014;42:1127-1129.
21. Kurt B, Flynn P, Shenep JL, et al. Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer 2008;113:376-382.
22. Okamoto Y, Ribeiro RC, Srivastava DK, Shenep JL, Pui CH, Razzouk BI. Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. J Pediatr Hematol Oncol 2003;25:696-703.
23. Hospital Compare. Medicare website. https://www.medicare.gov/hospitalcompare/search.html. Updated 2017. Accessed February 17, 2017.
24. Masnick M, Morgan DJ, Sorkin JD, et al. Lack of patient understanding of hospital-acquired infection data published on the Centers for Medicare and Medicaid Services Hospital Compare website. Infect Control Hosp Epidemiol 2016;37:182-187.
25. Masnick M, Morgan DJ, Macek MD, et al. Improving the understanding of publicly reported healthcare-associated infection (HAI) data. Infect Control Hosp Epidemiol 2016:1-6.
26. Rajwan YG, Barclay PW, Lee T, Sun IF, Passaretti C, Lehmann H. Visualizing central line-associated blood stream infection (CLABSI) outcome data for decision making by health care consumers and practitioners-an evaluation study. Online J Public Health Inform 2013;5:218.